Recombinant Human Immunodeficiency Pr55gagVirus-like Particles Presenting Chimeric Envelope Glycoproteins Induce Cytotoxic T-Cells and Neutralizing Antibodies

This publication has 71 references indexed in Scilit:

• Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I‐restricted epitope presentation
  European Journal of Immunology, 1995
• Humoral and Cellular Immune Responses in Rhesus Macaques Infected with Human Immunodeficiency Virus Type 2
  AIDS Research and Human Retroviruses, 1995
• US puts large-scale AIDS vaccine trials on ice as ‘premature’
  Nature, 1994
• Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses
  Journal of General Virology, 1993
• Strict peptide length is not required for the induction of cytotoxic T lymphocyte‐mediated antiviral protection by peptide vaccination
  European Journal of Immunology, 1993
• Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
  The Lancet, 1992
• Studies on processing, particle formation, and immunogenicity of the HIV-1gag gene product: a possible component of a HIV vaccine
  Archives of Virology, 1992
• A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx
  Cellular Immunology, 1991
• Vaccination of class I major histocompatibility complex (MHC)‐restricted murine CD8⁺ cytotoxic T lymphocytes towards soluble antigens: immunostimulating‐ovalbumin complexes enter the class I MHC‐restricted antigen pathway and allow sensitization against the immunodominant peptide
  European Journal of Immunology, 1991
• Cytotoxic T Cells in Cytomegalovirus Infection
  New England Journal of Medicine, 1982